Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Discontinuation of the clinical development of fusion inhibitor T-1249.

× No keyword cloud information.

12 in total

1. The appealing story of HIV entry inhibitors : from discovery of biological mechanisms to drug development.

Authors: Antonella Castagna; Priscilla Biswas; Alberto Beretta; Adriano Lazzarin
Journal: Drugs Date: 2005 Impact factor: 9.546

2. A Helical Short-Peptide Fusion Inhibitor with Highly Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.

Authors: Shengwen Xiong; Pedro Borrego; Xiaohui Ding; Yuanmei Zhu; Andreia Martins; Huihui Chong; Nuno Taveira; Yuxian He
Journal: J Virol Date: 2016-12-16 Impact factor: 5.103

3. Improving the safety of a conditional-live human immunodeficiency virus type 1 vaccine by controlling both gene expression and cell entry.

Authors: Atze T Das; Chris E Baldwin; Monique Vink; Ben Berkhout
Journal: J Virol Date: 2005-03 Impact factor: 5.103

4. Broad antiviral activity and crystal structure of HIV-1 fusion inhibitor sifuvirtide.

Authors: Xue Yao; Huihui Chong; Chao Zhang; Sandro Waltersperger; Meitian Wang; Sheng Cui; Yuxian He
Journal: J Biol Chem Date: 2012-01-06 Impact factor: 5.157

Review 5. Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs.

Authors: Jill M Steinbach
Journal: Cell Mol Life Sci Date: 2014-10-17 Impact factor: 9.261

6. Peptide-Based HIV Entry Inhibitors.

Authors: Jing Pu; Qian Wang; Shibo Jiang
Journal: Adv Exp Med Biol Date: 2022 Impact factor: 2.622

7. HIV-1 fusion inhibitor peptides enfuvirtide and T-1249 interact with erythrocyte and lymphocyte membranes.

Authors: Pedro M Matos; Miguel A R B Castanho; Nuno C Santos
Journal: PLoS One Date: 2010-03-23 Impact factor: 3.240

8. Selection of T1249-resistant human immunodeficiency virus type 1 variants.

Authors: Dirk Eggink; Christopher E Baldwin; Yiqun Deng; Johannes P M Langedijk; Min Lu; Rogier W Sanders; Ben Berkhout
Journal: J Virol Date: 2008-04-23 Impact factor: 5.103

Review 9. HIV entry inhibitors and their potential in HIV therapy.

Authors: Keduo Qian; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal: Med Res Rev Date: 2009-03 Impact factor: 12.944

Review 10. Approaches for identification of HIV-1 entry inhibitors targeting gp41 pocket.

Authors: Fei Yu; Lu Lu; Lanying Du; Xiaojie Zhu; Asim K Debnath; Shibo Jiang
Journal: Viruses Date: 2013-01-11 Impact factor: 5.048